日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results

靶向淋巴结的mKRAS特异性两亲性疫苗治疗胰腺癌和结直肠癌：AMPLIFY-201 I期试验最终结果

期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-025-03876-4
Zev A Wainberg ，Colin D Weekes ，Muhammad Furqan ，Pashtoon M Kasi ，Craig E Devoe ，Alexis D Leal ，Vincent Chung ，James R Perry ，Thian Kheoh ，Lisa K McNeil ，Esther Welkowsky ，Peter C DeMuth ，Christopher M Haqq ，Shubham Pant # ，Eileen M O'Reilly #
肿瘤
肠癌
胰腺癌
LIF
MPL
KRAS
发表日期：2025
文献求助 收藏

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial

淋巴结靶向、mKRAS特异性两亲性疫苗在胰腺癌和结直肠癌中的应用：AMPLIFY-201 I期试验

期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-023-02760-3
Shubham Pant ，Zev A Wainberg ，Colin D Weekes ，Muhammad Furqan ，Pashtoon M Kasi ，Craig E Devoe ，Alexis D Leal ，Vincent Chung ，Olca Basturk ，Haley VanWyk ，Amy M Tavares ，Lochana M Seenappa ，James R Perry ，Thian Kheoh ，Lisa K McNeil ，Esther Welkowsky ，Peter C DeMuth ，Christopher M Haqq ，Eileen M O'Reilly
胰腺癌
LIF
MPL
肿瘤
肠癌
肿瘤免疫
RAS
发表日期：2024
文献求助 收藏

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C

阿达格拉西布联合或不联合西妥昔单抗治疗KRAS G12C突变型结直肠癌

期刊:New England Journal of Medicine
影响因子:78.5
doi:10.1056/NEJMoa2212419
Yaeger, Rona; Weiss, Jared; Pelster, Meredith S; Spira, Alexander I; Barve, Minal; Ou, Sai-Hong I; Leal, Ticiana A; Bekaii-Saab, Tanios S; Paweletz, Cloud P; Heavey, Grace A; Christensen, James G; Velastegui, Karen; Kheoh, Thian; Der-Torossian, Hirak; Klempner, Samuel J
RAS
肿瘤
肠癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non-Small Cell Lung Cancer Patients

循环游离KRAS G12C的早期变化可预测KRAS突变型非小细胞肺癌患者对阿达格拉西布的反应

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-0795
Paweletz, Cloud P; Heavey, Grace A; Kuang, Yanan; Durlacher, Emily; Kheoh, Thian; Chao, Richard C; Spira, Alexander I; Leventakos, Konstantinos; Johnson, Melissa L; Ou, Sai-Hong Ignatius; Riely, Gregory J; Anderes, Kenna; Yang, Wenjing; Christensen, James G; Jänne, Pasi A
肺癌
肿瘤
肿瘤免疫
细胞生物学
RAS
发表日期：2023
文献求助 收藏

Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial

Vocimagene Amiretrorepvec联合氟胞嘧啶与标准治疗对复发性高级别胶质瘤患者肿瘤切除术后生存率的影响：一项随机临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2020.3161
Cloughesy, Timothy F; Petrecca, Kevin; Walbert, Tobias; Butowski, Nicholas; Salacz, Michael; Perry, James; Damek, Denise; Bota, Daniela; Bettegowda, Chetan; Zhu, Jay-Jiguang; Iwamoto, Fabio; Placantonakis, Dimitris; Kim, Lyndon; Elder, Brad; Kaptain, George; Cachia, David; Moshel, Yaron; Brem, Steven; Piccioni, David; Landolfi, Joseph; Chen, Clark C; Gruber, Harry; Rao, Aliz R; Hogan, Daniel; Accomando, William; Ostertag, Derek; Montellano, Tiffany T; Kheoh, Thian; Kabbinavar, Fairooz; Vogelbaum, Michael A
胶质瘤
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone

局部高危前列腺癌的临床和生物学特征：促黄体生成素释放激素激动剂联合或不联合醋酸阿比特龙加泼尼松的随机术前研究结果

期刊:
影响因子:
doi:10.1016/j.eururo.2019.05.010
Efstathiou, Eleni; Davis, John W; Pisters, Louis; Li, Weimin; Wen, Sijin; McMullin, Ryan P; Gormley, Michael; Ricci, Deborah; Titus, Mark; Hoang, Anh; Zurita, Amado J; Tran, NamPhuong; Peng, Weimin; Kheoh, Thian; Molina, Arturo; Troncoso, Patricia; Logothetis, Christopher J
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2019
文献求助 收藏

Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials

循环肿瘤细胞数作为转移性去势抵抗性前列腺癌患者生存期延长的疗效指标：与前列腺特异性抗原在五项随机III期临床试验中的比较

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2017.75.2998
Heller, Glenn; McCormack, Robert; Kheoh, Thian; Molina, Arturo; Smith, Matthew R; Dreicer, Robert; Saad, Fred; de Wit, Ronald; Aftab, Dana T; Hirmand, Mohammad; Limon, Ana; Fizazi, Karim; Fleisher, Martin; de Bono, Johann S; Scher, Howard I
肿瘤
肿瘤免疫
细胞生物学
肿瘤细胞
前列腺癌
发表日期：2018
文献求助 收藏

Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide

接受阿帕鲁胺治疗的去势抵抗性前列腺癌患者的雄激素受体突变

期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdx283
Rathkopf, D E; Smith, M R; Ryan, C J; Berry, W R; Shore, N D; Liu, G; Higano, C S; Alumkal, J J; Hauke, R; Tutrone, R F; Saleh, M; Chow Maneval, E; Thomas, S; Ricci, D S; Yu, M K; de Boer, C J; Trinh, A; Kheoh, T; Bandekar, R; Scher, H I; Antonarakis, E S
肿瘤
肿瘤免疫
信号转导
前列腺癌
免疫/内分泌
发表日期：2017
文献求助 收藏

Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis

在转移性激素敏感性前列腺癌男性患者中，将阿比特龙加入雄激素剥夺疗法：系统评价和荟萃分析

期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2017.07.003
Rydzewska, Larysa H M; Burdett, Sarah; Vale, Claire L; Clarke, Noel W; Fizazi, Karim; Kheoh, Thian; Mason, Malcolm D; Miladinovic, Branko; James, Nicholas D; Parmar, Mahesh K B; Spears, Melissa R; Sweeney, Christopher J; Sydes, Matthew R; Tran, NamPhuong; Tierney, Jayne F
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2017
文献求助 收藏

Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone

阿比特龙醋酸酯联合泼尼松治疗初治转移性去势抵抗性前列腺癌患者的无进展生存期预后指数模型

期刊:Clinical Genitourinary Cancer
影响因子:2.7
doi:10.1016/j.clgc.2017.07.014
Ryan, Charles J; Kheoh, Thian; Li, Jinhui; Molina, Arturo; De Porre, Peter; Carles, Joan; Efstathiou, Eleni; Kantoff, Philip W; Mulders, Peter F A; Saad, Fred; Chi, Kim N
肿瘤
前列腺癌
肿瘤免疫
发表日期：2017
文献求助 收藏